Latest:
Statistics Do Not Predict Patients' Fate
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Latest:
Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian Cancer
Latest:
FDA Grants Lynparza Priority Review for Frontline Maintenance in Ovarian Cancer
Latest:
Moving Away from Chemotherapy to Treat HR-Positive/HER2-Negative Metastatic Breast Cancer
Latest:
'Out of the Blue' Diagnosis Linked to a Family History of Cancer Now Empowers Others